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Recent studies have suggested the use of lipoproteins as an adjuvant treatment o f lethal gram-negative  
infections. However, other important m icroorganism s for the etiology o f  sepsis, such as Candida species, grow 
better in lipid-rich environm ents. We investigated the effect o f hyperlipoproteinemia on systemic candidiasis  
in low-density-lipoprotein-receptor-deficient (LDLR _ /~) mice, in which the loss of the receptor results in a 
seven- to ninefold-higher plasma LDL level than that in their wild-type littermates (C57BL/6J). LDLR- / _  mice 
died earlier, and the outgrowth o f Candida albicans in the kidneys and livers o f  L D L R -7“ mice was significantly  
higher compared with that o f  controls. After infection, circulating cytokine concentrations were significantly  
higher in LD LR -7 -  mice. In vitro, C. albicans grew better in plasm a sam ples of LD LR -7 -  mice than in control 
plasm a sam ples and peritoneal m acrophages of LDLR “ 7- mice challenged with heat-killed C. albicans pro­
duced more cytokines than did those of controls. This latter phenom enon was probably due to increased  
binding o f yeast cells to m acrophages of LD LR “ 7“ mice. These data suggest that hyperlipoproteinemia is 
deleterious in systemic candidiasis.
Acute disseminated candidiasis is a life-threatening condi­
li that occurs predominantly in im m unocom prom ised hosts, 
e mortality rate associated with disseminated candidiasis is 
Ji (31), and the incidence of this disease has increased in 
:ent years (1, 3). Candida albicans ranks fourth am ong the 
nanisms most frequently isolated from blood cultures in the 
lited States (1). Clinically, systemic candidiasis sometimes 
mics gram-negative sepsis. Viable Candida cells and cell wall 
nstituents are able to induce the synthesis of proinflamma- 
ry cytokines in vitro (13, 14, 18), similar to gram-negative 
cteria and their lipopolysaccharide (LPS) com ponent (23). 
nvcver, the role of these cytokines in systemic candidiasis is 
>bably beneficial ra ther than deleterious (20, 26). In con- 
; ist, the induction of proinflammatory cytokines, such as in- 
leukin-ltt (IL-lcx) and IL - lß  and tum or necrosis factor al- 
pua (T N F-a) , is merely a deleterious event in gram-negative 
 ^ psis (4) and trea tm ent aimed at blocking cytokine action has 
P'oved beneficial in various experimental models (2, 27, 30). In 
" psis in humans, anticytokine strategies have not been suc- 
‘ ssful so far. This is the reason why the focus of several recent 
idies has been on the capacity of lipoproteins in the circu- 
ion to bind and neutralize LPS and subsequently inhibit 
lokine production. Preincubation of LPS with lipoproteins 
ior to injection into animals decreased mortality after LPS 
i ection (28). Moreover, in vivo infusion of lipoproteins mark- 
c ly reduced cytokinemia and mortality after LPS administra- 
t! 'H ( 1 1 ). Transgenic mice that express hum an apolipoprotein
1 at high levels and have elevated plasma high-density-li- 
p protein concentrations are protected  against LPS challenge 
( /). Furtherm ore, low-density-lipoprotein-receptor-deficient 
( DLR ) mice, in which the plasma LDL concentration is
increased seven to nine times ( 1 2 ), were significantly protected 
not only against lethal endotoxemia but also against lethal 
Klebsiella pneumoniae infection (21). In addition, an infusion 
of lipoproteins in rats protected the animals against mortality 
due to gram-negative bacterial sepsis in a model of cecal liga­
tion and puncture (24). Taken together, these experiments 
dem onstrate  the capacity of lipoproteins to neutralize LPS and 
support their potential use as adjuvants in the therapy of sep­
sis.
On the o ther hand, earlier in vitro studies of lipid-containing 
parenteral solutions introduced for clinical use suggested that 
certain microorganisms, such as C. albicans and Staphylococcus 
aureus, grew better  in a lipid-rich environment (5, 9, 16). 
Therefore, it is important to know the effect of hyperlipopro­
teinemia on the outcome of a systemic infection with these 
organisms before suggesting the application of infusion with 
lipoproteins as an adjuvant therapy in sepsis. In the present 
study, we assessed the influence of hyperlipoproteinemia on 
experimental systemic candidiasis in LD LR  7 mice.
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MATERIALS AND METHODS
Animals. Homozygous C57BL/6J LDLR mice and wild-type littermates 
were obtained from Jackson Laboratory (Bar Harbor, Maine) as mating pairs 
and bred in our local facility. For experiments, 6- to 8-wcek-oId mice, weighing 
20 to 25 g, were used. The animals were fed standard laboratory chow (Hope 
Farms, W oerden, The Netherlands) and housed under specific-pathogen-lree 
conditions. The experiments were approved by the ethical committee for animal 
experiments at the Catholic University Nijmegen.
C. albicans infection. C. albicans (strain UCS20), maintained on agar slants at 
4°C, was inoculated into 100 ml of Sabouraud broth and cultured for 24 h at 
37°C. After  three washes with pyrogen-free saline by centrifugation at 1,500 x  g ,  
the num ber of yeast cells was counted in a hemacytometer; occasional strings of 
two or more yeast cells were counted as 1 C. albicans CFU. The suspension was 
diluted to the appropriate  concentration with pyrogen-free saline. The viability 
of yeast cells was at least 98%, as confirmed by plating serial dilutions on 
Sabouraud dextrose agar plates. Mice were injected intravenously (i.v.) in the 
retro-orbital plexus with 10" or 107 CFU of C. albicans. Survival was assessed 
daily for 14 days in groups o f  at least 15 animals. In separate groups, after 4 h and 
1 and 3 days, subgroups of  live mice were killed by cervical dislocation and blood 
samples were collected for the m easurem ent of  plasma cytokine concentrations.
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The outgrowth of  microorganisms from the livers, spleens, and kidneys of ani­
mals was quantified on days 1 and 3 after C. albicans injection. For this purpose, 
the organs were removed aseptically, weighed, and homogenized in sterile saline 
in a tissue grinder. The number of viable C. albicans cells in tissue samples was 
determined by plating serial dilutions on Sabouraud dextrose agar plates as 
described previously (15), and CFU were counted after overnight incubation at 
37°C. The results were expressed as the log CFU per gram of tissue.
Ex vivo cytokine production. Resident peritoneal macrophages were harvested 
by rinsing the peritoneal cavity aseptically with cold phosphate-buffered saline 
containing 0.38% (wt/vol) sodium citrate. After centrifugation, cells were rcsus- 
pended in RPMI 1640 (Dutch modification; Flow Laboratories, Irvine. United 
Kingdom) containing 1 mM pyruvate, 2 mM L-glutamine, and 100 fxg of genta- 
micin per ml and incubated for 1 h at 37°C (lO'Vwcil) in 96-well microtiter plates 
(Costar Corporation. Cambridge, Mass.). N onadherent cells were discarded, and 
the remaining cell population consisted of more than 90% macrophages, as 
assessed by light microscopy. Heat-killed (30 min, 100°C) C. albicans cells were 
washed three times in RPMI 1640 (final concentration, 2 X It)7 CFU/ml). Two 
hundred microliters of  suspension containing 10*’ microorganisms in RPMI 1640 
was added to peritoneal macrophages and incubated at 37°C. After 24 h, super- 
natants were collected and stored at —70°C until assayed. To the remaining 
macrophages, 200 fxl of RPMI 1640 was added, and cells were disrupted by three 
freeze-thaw cycles to determine the cell-associated cytokine contents. The sam ­
ples were stored at -7 0 °C  until assayed.
Cytokine measurements. TNF-ct. IL - la .  and IL - lß  concentrations were de­
termined by specific radioimmunoassays developed in our laboratory, as previ­
ously described (21).
C. albicans binding studies. C. albicans cells were radioiodinated by the iodo- 
gen method (8) with minor modifications. Briefly. 10s C. albicans cells in 50 mM 
phosphate buffer (pH 7.2) were incubated in an iodogen-coated vial (20 |j.g/100 
|xI) in the presence of 300 |j.Ci of N a 12:'I (specific activity, 15 mCi/|ig: Amersham) 
in a total volume of  100 p. I. After 15 min of incubation, the suspension was 
washed three times with phosphate-buffered saline and resuspended in RPMI 
1640 containing 1 mM of pyruvate. 2 mM of L-glutamine. and 100 p.g of genta- 
micin per ml (labelling efficiency. 45%). Peritoneal macrophages from LDLR 
and control mice were collected as described above. Macrophages (2 X H P )  were 
incubated with 106 CFU of radioiodinated C. albicans in a total volume of  200 pi 
of RPMI 1640 at 37°C in 96-well microtiter plates. After 5, 15. and 30 min, the 
supernatant was discarded and the radioactivity associated with adherent cells 
was measured with a gamma counter. Nonspecific binding was determined in 
wells in which C. albicans cells were incubated in the absence of macrophages. 
Total binding of C. albicans cells to macrophages (including both specific binding 
to receptors and nonspecific binding through membrane hydrophobicity or o ther  
nonspecific interactions) was determined by subtracting the binding of C. albi­
cans cells to plastic from total counts.
Growth of C. albicans in vitro. To investigate whether the growth of C. albicans 
in the plasma of  L D L R _/~ mice is similar to that in plasma of control mice, 2 X 
104 CFU of C. albicans were incubated in plasma samples obtained from 
LD LR ~ and control mice diluted 50% with Sabouraud broth in 10-ml glass 
lubes (Hospidex, Nieuwkoop. The Netherlands) in a final volume of  2 ml. After 
12 and 24 h of incubation at 37°C, aliquots of 0.1 ml were removed, serial 
dilutions were plated on Sabouraud agar, and CFU were counted after overnight 
incubation at 37°C. The adherence of C. albicans cells to tubes was checked and 
found to be less than 1% of total counts.
Determination of plasma lipids. Cholesterol and triglycerides were d e te r ­
mined by enzymatic methods with a Hitachi 747 analyzer.
Statistical analysis. The survival curves for control and L D L R _/" mice were 
compared by the Kaplan-Meycr log rank test. Differences in concentrations of 
cytokines and in organ counts of microorganisms were analyzed by the Mann- 
Whitney U test. Differences were considered significant at P <  0.05. All exper­
iments were performed at least twice.
RESULTS
C. albicans infection. Plasma cholesterol concentrations de­
creased significantly during C. albicans infection in both mouse 
strains (P  <  0.05) but rem ained three to four times higher in 
LD LR  mice than in control mice (P <  0.01) (Table 1). The
mice were twoinitial plasma triglyceride levels in LD LR 
times higher than those of controls (P  <  0.01). Four hours 
after infection, triglyceride levels decreased significantly in 
L D L R " 7” mice (P  <  0.05) and only marginally in control 
animals (P  >  0.05) (Table 1). The triglyceride levels 4 h after 
C. albicans infection did not differ significantly between the 
two mouse strains (P >  0.05) (Table 1). A fter i.v. injection of 
either IO6 or 107 C FU  of C. albicans, L D L R  mice died 
significantly earlier than did control animals (P  <  0.05) (Fig. 
1).
O ne day after infection with 10° C FU  of C. albicans, yeast
TABLE 1. Plasma cholesterol and triglyceridc concentrations 
before and 4 h after C. albicans infection in LDLR
and C57BL/6J mice"
Mouse
strain Time
Mean concn (mmol/liter) ±  SD'1
Cholesterol Triglycerides
L D L R -7“ Before 9.55 ±  1.11* 1.25 ± 0.33*
After 6.76 ±  0.92*,** 0.58 ± 0.05**
C57BL/6J Before 2.25 ±  0.45 0.65 ± 0 .12
After 1.84 ±  0.09** 0.49 ±0.11
“ Mice were infected i.v. with 10f> CFU of C. albicans. Each group consisted of 
five mice.
h *, P <  0.01 for comparison between results for LDLR /_ and control mice; 
**, P <  0.05 for comparison between results before and aller C. albicans infec­
tion.
outgrowth in the kidneys of LD LR  mice was significantly 
higher com pared with that of controls; 3 days after infection, 
outgrowth of C. albicans was increased in both the kidneys and 
livers of LD LR  mice (Table 2). No difference in the ou t­
growth of C. albicans in the spleen was detected between the 
two mouse strains (Table 2).
Four hours after infection, plasma T N F -a  concentrations 
were below the detection limit and IL - la  concentrations were 
higher in LD LR  mice than in controls (140 ±  22 versus 
78 ±  48 pg/ml, respectively; P  <  0.05). Circulating IL - lß  con­
centrations were similar in both strains (56 ±  29 versus 37 ±  28 
pg/ml, respectively; P  >  0.05). Plasma T N F -a  concentrations 
were significantly higher in LD LR  mice com pared with 
those of control animals at both 24 (42 ±  5 versus 18 ±  4 
pg/ml, respectively; P <  0.01) and 72 (302 ±  237 versus 98 ± 
58 pg/ml, respectively; P <  0.02) h after infection (Fig. 2). No 
differences in plasma IL - la  and IL - lß  concentrations were 
observed at these time points (Fig. 2).
In vitro cytokine production. We investigated the capacity of 
peritoneal macrophages of both mouse strains to produce cy­
tokines when stimulated in vitro with heat-killed C. albicans. 
C om pared  with those of controls, the T N F -a  concentrations in
supernatants from m acrophages of L D L R 7- mice were sig­
nificantly higher (Fig. 3a). The IL - la  and IL - lß  concentrations 
were only marginally increased (Fig. 3a). The cell-associated 
IL - la  concentration was significantly increased in m acro­
phages of LD LR  mice, but the cell-associated T N F -a  and
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FIG. 1. Survival during C. albicans infection. L D L R _/ mice (closed sym­
bols) infected with either 107 (triangles) or 10*’ (circles) CFU  of C. albicans died 
significantly earlier than did C57BL/6J mice (open symbols) (P <  0.05; Kaplan- 
Meycr log rank test). The data are pooled results of  two experiments with at least 
15 animals per group.
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TABLE 2. Outgrowth of C. albicans in the organs of LDLR and 
C57BL/6J mice after infection with 106 CFU of C. albicans
D ISC USSIO N
Mouse strain Organ Day Log CFU/g of tissue"
L D L R _/_ Kidney I 6.3 ± 0.5*
3 7.4 ±  0.3**
Liver I 4.8 ±  0.3
3 5.2 ±  0.2**
Spleen I 4.9 ±  0.2
3 5.1 ±  0.5
C57BL/6J Kidney I 5.9 ±  0.2
3 6.8 ± 0.3
Liver 1 4.8 ±  0.1
3 4.9 ± 0.1
Spleen 1 5.1 ± 0.2
3 5.0 ±  0.2
" Data are means ±  standard deviations of pooled data from two experiments 
with 10 animals per group. *, P <  0.01; **, P <  0.05.
IL -lß  concentrations did not differ between the two mouse 
strains (Fig. 3b).
C. albicans b in d in g .  To investigate the total binding of C. 
ilbicans to macrophages from the two mouse strains, we incu­
bated radioiodinated C. albicans cells with m acrophages (5:1 
ratio) and determ ined the am ounts bound to macrophages 
after 5, 10, and 30 min of incubation. The binding of yeast cells 
to m acrophages of LD LR mice was increased and more 
rapid com pared to that of control m acrophages (Fig. 4).
Growth o f C. albicans in vitro. To investigate w hether the 
iutgrowth of C. albicans in the organs of LD LR  mice is due
o enhanced growth of yeast cells in a lipoprotein-rich envi­
ronment, we com pared  the in vitro growth of 104 CFU  of C. 
ilbicans in plasma samples (diluted 1: 1 with Sabouraud me- 
Jium) of LD LR  mice and controls. The capacity of 
LDLR plasma to inhibit the outgrowth of C. albicans was 
decreased com pared  with that of control plasma, as shown by 
he growth of C. albicans in the two types of plasma samples 
ifter 12 [(7.2 ±  2.4) X 103 versus (2.4 ±  1.5) X 103  CFU/ml, 
cspectively; P <  0.Ü5J and 24 [(4.2 ±  1.6) X 103 versus (1.5 ±  
1.0) X 103 CFU/ml, respectively; P <  0.05] h of incubation.
The main conclusion from the present study is that hyperli­
poproteinem ia has deleterious effects on the outcome of se­
vere C. albicans infection, in contrast to gram-negative bacte­
rial infections. We have shown that LD LR  mice, with 
seven- to nine-times-higher LDL levels, are more susceptible 
to C. albicans infection than are their wild-type littermates. 
The earlier mortality of LD LR mice was associated with 
increased outgrowth of C. albicans in their organs, and these 
mice produced significantly more proinfiammatory cytokines 
than did control mice.
In general, mortality after infection may be due to lethal 
cytokincmia or to functional impairment by the growth of 
microorganisms in the organs of an animal. The increased 
susceptibility of LD LR  mice to C. albicans is likely to be 
due to the latter mechanism, because C. albicans did not in­
duce an impressive cytokinemia. The hypothesis that cytokines 
are not responsible for the deaths of animals during C. albicans 
infection is in agreem ent with studies showing that the stimu­
lation of neutrophils and macrophages by T N F  and IL-1 en­
hanced their capability to kill C. albicans cells (6 , 29), whereas 
anti-TNF antibodies (26) or pharmacologic inhibition of proin­
fiammatory cytokines proved to be deleterious during severe 
C. albicans infection (2 0 ). Thus, proinfiammatory cytokines 
seem to play a beneficial ra ther than a deleterious role in the 
defense against C. albicans. It should be noted that despite the 
greater cytokine response, LD LR mice were not protected 
against C. albicans infection, probably due to the overwhelm­
ing outgrowth of yeast cells in their organs.
It may be hypothesized that the enhanced outgrowth of C. 
albicans in the organs of LD LR  mice is due to elevated 
lipoprotein concentrations. Normal serum has a candidicidal 
effect (2 2 ), and as shown by in vitro growth experiments, this 
property was significantly decreased in plasma samples from 
LD LR  mice. This effect may be due to the use of lipopro­
teins as a nutrition factor by C. albicans, as has been suggested 
by earlier studies showing increased growth of C. albicans in 
lipid-containing parenteral solutions com pared with that in 
formulations without lipid contents (5, 9, 16). A nother possible 
mechanism by which lipoproteins could influence C. albicans 
growth is interaction with o ther plasma factors. We cannot
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FIG. 2. In vivo cytokine concentrations during C. albicans infection. Shown are circulating concentrations of proinfiammatory cytokines in control (open bars) and
I D L R - / ~ (shaded bars) mice at 4, 24, and 72 h after the injection of  106 CFU of C. albicans. *, P <  0.05.
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FIG. 3. In vitro cytokine production capacity of peritoneal macrophages. In 
vitro production of secreted (a) and cell-associated (b) cytokines by peritoneal 
macrophages of  control (open bars) and LDLR (shaded bars) mice was 
stimulated with heat-killed C. (ilbicans (2 X H) CFU/ml). *, P <  0.05.
exclude the possibility that plasma candidicidal factors, such as 
platelet microbicidal protein (32) and the calprotectin complex
(19), are bound and inactivated by lipoproteins.
The higher cytokine concentrations during infection in 
LD LR mice, com pared with those of controls, were prob­
ably at least in part a response of the host against enhanced C. 
albicans outgrowth in the organs of LDLR mice. However, 
surprisingly, stimulated in vitro with heat-killed C. albicans, 
macrophages of LDLR mice produced significantly more 
TNF-cy and IL - la  than macrophages of control mice did. Most 
likely, this was due to the observed increased binding of C. 
albicans to macrophages of LDLR mice com pared with 
that of control macrophages. This phenom enon may be ex­
plained by the influence of constitutively increased lipoprotein 
concentrations in LD LR mice on the Cam//¿/a-binding p ro­
teins on macrophage. It has been shown previously that hyper­
cholesterolemia is able to modify the num ber and clustering of 
o ther receptors, such as the LPS receptor CD 14 (7, 25). E ar­
lier, we observed similar higher binding of radiolabelled LPS to 
macrophages of LD LR mice, followed by higher cytokine 
production (21). Thus, similar changes in the num ber and/or
ooo
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FIG. 4. C. albicans binding to peritoneal macrophages. Peritoneal macro­
phages of  control (open circles) and LD LR (closed circles) mice were incu­
bated for various time intervals with radioiodinated C. albicans cells ( 1:5 ratio of 
macrophages to C. albicans cells). *, P <  0.05.
clustering of CY//i¿//Y/í/-binding proteins may facilitate the bind­
ing of C. albicans to macrophages of LD LR mice, with a 
subsequent increase in cytokine production. Hyperlipoprotein­
emia could also modify the hydrophobicity of cells, which may 
also influence the adherence of C. albicans to macrophages, as 
has been shown for endothelial cells (10). Which of these 
mechanisms is responsible for the observed increase in cyto­
kine production by macrophages of LD LR mice is under 
study.
An alternative desirable experiment to our model in o rder to 
investigate the influence of hyperlipoproteinemia in C. albi­
cans infection would have been to infuse lipoproteins into 
animals before and during infection. However, an infusion of 
lipoproteins into mice is not possible and o ther models of 
lipoprotein infusion in rabbits (11) and rats (24) are short-term 
models that are not suitable for sustained lipid infusion during 
systemic candidiasis. Therefore, the genetically modified 
mouse model is a good alternative for studying the in vivo 
effects of hyperlipoproteinemia in models of sustained infec­
tion.
In conclusion, hyperlipoproteinemia has deleterious effects 
on the course of acute disseminated C. albicans infection, in 
contrast to its beneficiai effect in gram-negative infection. Al­
though no epidemiological studies have been done to show a 
relationship between hyperlipoproteinemia and increased sus­
ceptibility to C. albicans, an infusion of lipoproteins into a 
patient with disseminated candidiasis under the presumptive 
diagnosis of gram-negative sepsis may prove deleterious. These 
divergent effects of hyperlipoproteinemia should be taken into 
account when the use of lipoproteins as an adjuvant treatm ent 
of sepsis is considered.
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